Aveo Capital Partners’s Labcorp LH Stock Holding History

Aveo Capital Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,815	Closed	-$367K	–	360
2022 Q4	$367K	Buy	1,815 +297	+20%	+$58K	0.06%	236
2022 Q3	$267K	Buy	+1,518	New	+$311K	0.05%	231

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Aveo Capital Partners's LH Position: Q1 2023 in Review

Aveo Capital Partners sold out of Labcorp (LH) in Q1 2023, closing a stake of 1,815 shares — an estimated $367K sold.

Aveo Capital Partners first reported a position in LH in Q3 2022 and held it in 2 quarters. The position peaked at $367K in Q4 2022. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

Aveo Capital Partners reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
Aveo Capital Partners sold 1,815 Labcorp shares in Q1 2023, an estimated $367K.
Aveo Capital Partners first reported a position in Labcorp in Q3 2022 and held it in 2 quarters.
Aveo Capital Partners's Labcorp position peaked at $367K in Q4 2022.
940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Aveo Capital Partners's 13F filing for Q1 2023, filed 3 May 2023.